2 unchanged sentences
Our common stock trades under the symbol “MXCT” on the Nasdaq Global Select Market.
−Removed: Trading of our common stock commenced on July 30, 2021 in connection with our initial public offering, or IPO, in the United States.
+Added: Trading of our common stock commenced on July 30, 2021 in connection with our initial public offering (“IPO”), in the United States.
Prior to that time, there was no established public market for our common stock in the United States.
−Removed: Since 2016, our common stock has traded on AIM, a market operated by the London Stock Exchange, and currently trades on AIM under the symbol “MXCT.”
+Added: Since 2016, our common stock has traded on AIM, and currently trades on AIM under the symbol “MXCT.”
Holders of Our Common Stock
−Removed: As of December 31, 2021, there were approximately 118 holders of record of our common stock.
−Removed: The actual number of holders of our common stock is greater than this number of record holders and includes stockholders who are beneficial owners, but whose shares are held in “street name” by brokers or held by other “nominees.” The number of holders of record also does not include stockholders whose shares may be held in trust by other entities.
+Added: As of March 8, 2023, there were approximately 160 holders of record of our common stock.
+Added: The actual number of holders of our common stock is greater than this number of record holders and includes stockholders who are beneficial owners, but whose shares are held in “street name” by brokers or held by other nominees.
+Added: The number of holders of record also does not include stockholders whose shares may be held in trust by other entities.
Dividend Policy
1 unchanged sentence
We currently intend to retain all available funds and future earnings, if any, to fund the development and expansion of our business, and we do not anticipate declaring or paying any cash dividends in the foreseeable future.
−Removed: Stock Performance Graph
−Removed: The following graph compares the cumulative total stockholder return on an investment in our common stock relative to the cumulative total returns of the NASDAQ Composite Index and the NASDAQ Biotechnology Index through December 31, 2021.
−Removed: The graph assumes $100 was invested at the market close on July 30, 2021, which was the date on which our common stock began trading on the Nasdaq Global Select Market.
−Removed: Data for the NASDAQ Composite Index and the NASDAQ Biotechnology Index assume reinvestment of dividends;
−Removed: however, no dividends have been declared on our common stock to date and, therefore, the cumulative total return calculation for us is based upon our stock price appreciation or depreciation and does not include any reinvestment of cash dividends.
−Removed: The comparisons shown in the graph below are based upon historical data and are not necessarily indicative of, nor intended to forecast, the potential future performance of our common stock.
−Removed: This graph shall not be deemed to be “soliciting material” or to be “filed” with the SEC for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or the Exchange Act, or incorporated by reference into any filing by us under the Securities Act of 1933, as amended, or under the Exchange Act.
Recent Sales of Unregistered Equity Securities
11 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.